Clinical Trials Directory

Trials / Unknown

UnknownNCT03218527

Influence of Circulating Endothelial Progenitor Cells and Modifiable Vascular Risk Factors on Carotid Plaque Vulnerability

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Ischemic stroke is a leading cause of death and disability worldwide. Atherosclerosis, responsible for the 20% of ischemic strokes, is characterized by lipid accumulation in the artery wall that leads to chronic inflammation, cell proliferation and ultimately to vessel stenosis. One of the main features related to plaque progression and vulnerability is inflammation. Positron emission tomography with 18-fluorodeoxyglucos (18-FDG PET) allows an accurate quantification of plaque inflammation and it has been proved its usefulness in predicting early stroke recurrences. The investigators aim to test how modifiable vascular risk factors influence plaque inflammation assessed by 18-FDG PET. In addition, investigators will assess the association of this inflammation and circulating endothelial progenitor cells

Conditions

Timeline

Start date
2015-10-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2017-07-14
Last updated
2017-07-14

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03218527. Inclusion in this directory is not an endorsement.